|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1990-3-2
|
|
pubmed:abstractText |
Ten Alzheimer's disease patients underwent a trial of oral tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there was no clear therapeutic effect. Three of six patients able to continue in long-term treatment showed measurable cognitive improvement, but only one displayed clinically obvious improvement.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
147
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
239-42
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2405720-Aged,
pubmed-meshheading:2405720-Alzheimer Disease,
pubmed-meshheading:2405720-Aminoacridines,
pubmed-meshheading:2405720-Clinical Trials as Topic,
pubmed-meshheading:2405720-Double-Blind Method,
pubmed-meshheading:2405720-Drug Therapy, Combination,
pubmed-meshheading:2405720-Humans,
pubmed-meshheading:2405720-Male,
pubmed-meshheading:2405720-Phosphatidylcholines,
pubmed-meshheading:2405720-Tacrine
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
|
|
pubmed:affiliation |
VA Medical Center, Sepulveda, Calif 91343.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, Non-P.H.S.,
Controlled Clinical Trial
|
